Exercise for intermittent claudication

R Lane, A Harwood, L Watson… - Cochrane Database of …, 2017 - cochranelibrary.com
Background Exercise programmes are a relatively inexpensive, low‐risk option compared
with other, more invasive therapies for treatment of leg pain on walking (intermittent …

A systematic review of the uptake and adherence rates to supervised exercise programs in patients with intermittent claudication

AE Harwood, GE Smith, T Cayton, E Broadbent… - Annals of vascular …, 2016 - Elsevier
Background Intermittent claudication (IC) is a common and debilitating symptom of
peripheral arterial disease and is associated with a significant reduction in a sufferer's …

Carnitine derivatives: clinical usefulness

M Malaguarnera - Current opinion in gastroenterology, 2012 - journals.lww.com
Carnitine derivatives: clinical usefulness : Current Opinion in Gastroenterology Carnitine
derivatives: clinical usefulness : Current Opinion in Gastroenterology Log in or Register …

Pharmacological effects and clinical applications of propionyl-L-carnitine

C Mingorance, R Rodriguez-Rodriguez… - Nutrition …, 2011 - academic.oup.com
Abstract Propionyl-L-carnitine (PLC) is a naturally occurring derivative of carnitine that plays
an important role in the metabolism of both carbohydrates and lipids, leading to an increase …

Critical update for the clinical use of L-carnitine analogs in cardiometabolic disorders

C Mingorance, R Rodríguez-Rodríguez… - Vascular health and …, 2011 - Taylor & Francis
Acetyl-L-carnitine (ALC) and propionyl-L-carnitine (PLC) are two naturally occurring
carnitine derivates formed by carnitine acetyltransferase. The beneficial cardiovascular …

Effect of propionyl-L-carnitine on a background of monitored exercise in patients with claudication secondary to peripheral artery disease

WR Hiatt, MA Creager, A Amato… - Journal of …, 2011 - journals.lww.com
METHODS This study was a randomized, placebo-controlled, double-blinded, multicenter
trial conducted at 10 sites in the United States, from May 2006 through March 2008. The …

The role of PPAR alpha in perfluorooctanoic acid induced developmental cardiotoxicity and l-carnitine mediated protection–Results of in ovo gene silencing

M Zhao, Q Jiang, M Geng, L Zhu, Y Xia… - Environmental …, 2017 - Elsevier
Perfluorooctanoic acid (PFOA) is a persistent organic pollutant. This study established an in
ovo peroxisome proliferator-activated receptor alpha (PPAR alpha) silencing model in …

A systematic review to evaluate the effectiveness of carnitine supplementation in improving walking performance among individuals with intermittent claudication

CL Delaney, JI Spark, J Thomas, YT Wong, LT Chan… - Atherosclerosis, 2013 - Elsevier
OBJECTIVE: To evaluate the evidence for the use of carnitine supplementation in improving
walking performance among individuals with intermittent claudication. DESIGN: Systematic …

Potential protective effects of l-carnitine against neuromuscular ischemia-reperfusion injury: From experimental data to potential clinical applications

A Moghaddas, S Dashti-Khavidaki - Clinical Nutrition, 2016 - Elsevier
Background & aim Ischemia-reperfusion (I/R) injury plays important role in morbidity and
mortality in several pathologies, including myocardial infarction, ischemic stroke, acute …

Propionyl l-carnitine: intermittent claudication and peripheral arterial disease

GM Andreozzi - Expert opinion on pharmacotherapy, 2009 - Taylor & Francis
Peripheral arterial disease (PAD) is a clinical manifestation of underlying aorto-iliac and leg
atherosclerosis that is characterized by different stages of stenosis and obstruction. It affects …